Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated otherwise.
View Top Employees from Terns PharmaceuticalsWebsite | http://ternspharma.com/ |
Ticker | TERN |
Revenue | $10 million |
Funding | $197 million |
Employees | 66 (58 on RocketReach) |
Founded | 2017 |
Address | 1065 E Hillsdale Blvd Suite 100, Foster City, California 94404, US |
Phone | (650) 525-5535 |
Fax | (650) 275-4395 |
Technologies |
JavaScript,
HTML,
Twitter
+27 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Terns Pharmaceuticals employee's phone or email?
The Terns Pharmaceuticals annual revenue was $10 million in 2024.
Bryan Yoon is the Chief Operating Officer and General Counsel of Terns Pharmaceuticals.
58 people are employed at Terns Pharmaceuticals.
Terns Pharmaceuticals is based in Foster City, California.
The NAICS codes for Terns Pharmaceuticals are [32541, 325, 3254, 32].
The SIC codes for Terns Pharmaceuticals are [28, 283].